High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment

CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,S

Harold Glucksberg, Rainer Storb, A Fefer et al. · Transplantation · 1974 · 3.7K citations

Medicine, Hematology, Immunology +14

Epstein–Barr Virus Infection

Jeffrey I. Cohen · New England Journal of Medicine · 2000 · 1.6K citations

Veterinary Medicine, Infectious Diseases, Microbiology +15

Infusion of Cytotoxic T Cells for the Prevention and Treatment of Epstein-Barr Virus–Induced Lymphoma in Allogeneic Transplant Recipients

Cliona M. Rooney, Colton A. Smith, Catherine Y. Ng et al. · Blood · 1998 · 1.1K citations

Life Sciences, Immunology, Oncology +15

Infusions of Donor Leukocytes to Treat Epstein-Barr Virus-Associated Lymphoproliferative Disorders after Allogeneic Bone Marrow Transplantation

Esperanza B. Papadopoulos, Marc Ladanyi, David Emanuel et al. · New England Journal of Medicine · 1994 · 1.1K citations · Full text

Medicine, Hematology, Immunology +12

Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study.

Rochelle E. Curtis, Lois B. Travis, Philip A. Rowlings et al. · PubMed · 1999 · 651 citations

Medicine, Hematology, Immunology +16